We provide the first evidence that LIMK1 is a novel kinase that, in synergy with CDK5, is responsible for phosphorylating β‐catenin at S191, leading to β‐catenin nuclear translocation and ultimately promoting ESCC metastasis. This evidence concerns the gene LIMK1 and esophageal squamous cell carcinoma.